Latest Stories
Why NeoGenomics (NEO) Shares Are Falling Today
Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 10.1% in the afternoon session after the company reported fourth-quarter results that beat expectations but issued a full-year 2026 forecast that fell short of analyst predictions.
RUSHA Q4 Deep Dive: Truck Orders Recover as Regulatory Clarity Boosts Market Confidence
Commercial vehicle retailer Rush Enterprises (NASDAQ:RUSH.A) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, but sales fell by 11.8% year on year to $1.77 billion. Its non-GAAP profit of $0.81 per share was 17.1% above analysts’ consensus estimates.
JELD Q4 Deep Dive: Operational Discipline and Cost Actions Amid Market Softness
Building products manufacturer JELD-WEN (NYSE:JELD) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, but sales fell by 10.5% year on year to $802 million. On the other hand, the company’s full-year revenue guidance of $3.03 billion at the midpoint came in 2.4% below analysts’ estimates. Its non-GAAP loss of $0.42 per share was 44.3% below analysts’ consensus estimates.
LZB Q4 Deep Dive: Retail Expansion Offsets Mixed Macroeconomic Environment, Margin Pressures Persist
Furniture company La-Z-Boy (NYSE:LZB) announced better-than-expected revenue in Q4 CY2025, with sales up 3.8% year on year to $541.6 million. On the other hand, next quarter’s revenue guidance of $570 million was less impressive, coming in 3.2% below analysts’ estimates. Its non-GAAP profit of $0.61 per share was 2.8% above analysts’ consensus estimates.
USNA Q4 Deep Dive: Omnichannel Push and Brand Expansion Shape Outlook Amid Margin Pressures
Health and wellness products company USANA Health Sciences (NYSE:USNA) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 5.9% year on year to $226.2 million. The company’s full-year revenue guidance of $962.5 million at the midpoint came in 0.7% above analysts’ estimates. Its non-GAAP profit of $0.60 per share was 46.3% above analysts’ consensus estimates.
Insulet (PODD) Shares Skyrocket, What You Need To Know
Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) jumped 5.6% in the afternoon session after the company posted strong fourth-quarter 2025 financial results that beat Wall Street's expectations.
Moody's (MCO) Stock Trades Up, Here Is Why
Shares of credit rating agency Moody's (NYSE:MCO) jumped 5.7% in the afternoon session after the company reported fourth-quarter financial results that beat Wall Street expectations and provided a strong forecast for the full year 2026.
Why Is Cadence Design Systems (CDNS) Stock Soaring Today
Shares of electronic design automation company Cadence Design Systems (NASDAQ:CDNS) jumped 9.2% in the afternoon session after the company reported better-than-expected fourth-quarter financial results and issued a strong outlook for 2026.
Why Palantir Technologies (PLTR) Stock Is Trading Up Today
Shares of data analytics company Palantir Technologies (NASDAQ:PLTR) jumped 4.6% in the afternoon session after an analyst at Mizuho upgraded the stock's rating and the company announced a strategic partnership with Rackspace Technology.
Why Are JELD-WEN (JELD) Shares Soaring Today
Shares of building products manufacturer JELD-WEN (NYSE:JELD) jumped 25.8% in the afternoon session after it reported fourth-quarter financial results that showed better-than-expected operational performance despite a decline in sales.